Considering that IC2 has a better inhibitory effect on breast cancer cell proliferation than ICT [10], we then detected MAPK signaling after IC2 treatment in MCF7 cells and found that P38, JNK and ERK were significantly activated. The gene discussed is MAPK8; the disease is breast cancer.